IL6 and colitis: Formononetin can reduce the expression of IL-6 to alleviate colitis symptoms in mice and inhibit JAK2/STAT3 signaling pathway transduction to protect against cerebral ischemia reperfusion injury (Wu et al., 2018; Yu et al., 2022).